Validation of a serum ELISA test for cyathostomin infection in equines.
Abstract: Cyathostomins are ubiquitous equine nematodes. Infection can result in larval cyathostominosis due to mass larval emergence. Although faecal egg count (FEC) tests provide estimates of egg shedding, these correlate poorly with burden and provide no information on mucosal/luminal larvae. Previous studies describe a serum IgG(T)-based ELISA (CT3) that exhibits utility for detection of mucosal/luminal cyathostomins. Here, this ELISA is optimised/validated for commercial application using sera from horses for which burden data were available. Optimisation included addition of total IgG-based calibrators to provide standard curves for quantification of antigen-specific IgG(T) used to generate a CT3-specific 'serum score' for each horse. Validation dataset results were then used to assess the optimised test's performance and select serum score cut-off values for diagnosis of burdens above 1,000, 5,000 and 10,000 cyathostomins. The test demonstrated excellent performance (Receiver Operating Characteristic Area Under the Curve values >0.9) in diagnosing infection, with >90% sensitivity and >70% specificity at the selected serum score cut-off values. CT3-specific serum IgG(T) profiles in equines in different settings were assessed to provide information for commercial test use. These studies demonstrated maternal transfer of CT3-specific IgG(T) in colostrum to newborns, levels of which declined before increasing as foals consumed contaminated pasture. Studies in geographically distinct populations demonstrated that the proportion of horses that reported as test positive at a 14.37 CT3 serum score (1,000-cyathostomin threshold) was associated with parasite transmission risk. Based on the results, inclusion criteria for commercial use were developed. Logistic regression models were developed to predict probabilities that burdens of individuals are above defined thresholds based on the reported serum score. The models performed at a similar level to the serum score cut-off approach. In conclusion, the CT3 test provides an option for veterinarians to obtain evidence of low cyathostomin burdens that do not require anthelmintic treatment and to support diagnosis of infection.
Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Publication Date: 2023-08-01 PubMed ID: 37536388DOI: 10.1016/j.ijpara.2023.07.001Google Scholar: Lookup The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
Background:
- Cyathostomins: These are a type of worm (nematode) that commonly infect horses. Their presence is widespread.
- Infection Consequences: When horses are infected, a condition called larval cyathostominosis can occur. This happens due to a sudden emergence of a large number of larvae from the worms.
- Faecal Egg Count (FEC) Tests: This is a test that checks horse feces for the number of worm eggs. However, this test has limitations. Although it tells you how many eggs are being shed by the worms, it doesn’t give a clear picture of the total number of worms in the horse. It also doesn’t provide information about worms that are in the mucus lining or the lumen (interior) of the intestines.
Previous Research:
- There’s been prior research on an ELISA (a type of laboratory test) called CT3, which detects antibodies (specifically IgG(T)) in horse serum. This test is useful for detecting worms that are present in the mucus lining or the lumen of the intestines.
Current Study:
- Objective: The researchers are trying to refine and validate the CT3 ELISA for commercial use. They have samples from horses for which they already know the worm burden.
- Optimisation: They improved the test by adding “calibrators” that help in quantifying the specific antibody (IgG(T)). With this quantification, they created a ‘serum score’ for each horse, indicating the level of infection.
- Validation: They used another set of samples to check how well the optimized test worked. They aimed to determine the right serum score values that would indicate worm burdens of 1,000, 5,000, and 10,000 worms.
- Performance: The test performed very well. Using statistical measures, they found that the test could accurately diagnose worm infections. Specifically, it had over 90% sensitivity (correctly identifying true infections) and more than 70% specificity (correctly identifying those without infections) at the chosen serum score thresholds.
Further Observations:
- They studied the pattern of these antibodies in various situations:
- They noticed that newborn horses (foals) initially get these antibodies from their mothers through colostrum (the first milk). This inherited protection drops over time, but then increases again as the foals start eating grass contaminated with the worms.
- When they studied horse populations in different geographical areas, they found that the number of horses testing positive for the worms (using the CT3 test) was related to the risk of worm transmission in that area.
Commercial Use:
- Based on their findings, they outlined criteria for using the test in a commercial setting.
- They developed mathematical models (logistic regression) to predict the chances that a horse’s worm burden exceeds certain thresholds based on its serum score. These models performed similarly to the direct serum score threshold method.
Conclusion:
- The CT3 test is valuable for veterinarians. It can help them identify horses with low worm burdens that may not need treatment. Moreover, it supports the diagnosis of worm infections in horses.
Cite This Article
APA
Lightbody KL, Austin A, Lambert PA, von Samson-Himmelstjerna G, Jürgenschellert L, Krücken J, Nielsen MK, Sallé G, Reigner F, Donnelly CG, Finno CJ, Walshe N, Mulcahy G, Housby-Skeggs N, Grice S, Geyer KK, Austin CJ, Matthews JB.
(2023).
Validation of a serum ELISA test for cyathostomin infection in equines.
Int J Parasitol.
https://doi.org/10.1016/j.ijpara.2023.07.001 Publication
Researcher Affiliations
- Austin Davis Biologics, Unit 1 Denfield Lodge, Great Addington, NN14 4BL, UK.
- Austin Davis Biologics, Unit 1 Denfield Lodge, Great Addington, NN14 4BL, UK.
- College of Health and Life Sciences, Aston University, Birmingham, B4 7ET, UK.
- Freie Universität Berlin, Institute for Parasitology and Tropical Veterinary Medicine, Robert-von-Ostertag-Str. 7, 14163 Berlin, Germany.
- Freie Universität Berlin, Institute for Parasitology and Tropical Veterinary Medicine, Robert-von-Ostertag-Str. 7, 14163 Berlin, Germany.
- Freie Universität Berlin, Institute for Parasitology and Tropical Veterinary Medicine, Robert-von-Ostertag-Str. 7, 14163 Berlin, Germany.
- Gluck Equine Research Center, University of Kentucky, Lexington, KY 40546, USA.
- INRAE, Université de Tours, UMR1282 ISP, F-37380, Nouzilly, France.
- INRAE, UE Physiologie Animale de l'Orfrasière, 37380 Nouzilly, France.
- Department of Population Health and Reproduction, School of Veterinary Medicine, University of California Davis, Davis, CA, USA.
- Department of Population Health and Reproduction, School of Veterinary Medicine, University of California Davis, Davis, CA, USA.
- School of Veterinary Medicine, Veterinary Sciences Centre, Belfield, Dublin 4, Ireland.
- School of Veterinary Medicine, Veterinary Sciences Centre, Belfield, Dublin 4, Ireland.
- The Horse Trust, Slad Lane, Princes Risborough, HP27 0PP, UK.
- The Horse Trust, Slad Lane, Princes Risborough, HP27 0PP, UK.
- Moredun Research Institute, Edinburgh, EH26 0PZ, UK.
- Austin Davis Biologics, Unit 1 Denfield Lodge, Great Addington, NN14 4BL, UK.
- Austin Davis Biologics, Unit 1 Denfield Lodge, Great Addington, NN14 4BL, UK. Electronic address: jacqui.matthews@austindavis.co.uk.
Conflict of Interest Statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.